|
|
Utilization of anticoagulants in the Czech Republic and the neighbouring countries of Central and Eastern Europe during 2007-2019
Šťastná Koblihová, Helena ; Malá, Kateřina (advisor) ; Rejmanová, Anna (referee)
Utilization of anticoagulants in the Czech Republic and the neigbouring countries of Central and Eastern Europe during 2007-2019 Supervisor: PharmDr. Kateřina Malá, Ph.D. Author: Mgr. Helena Šťastná Koblihová Charles University, Faculty of Pharmacy in Hradec Králové, Department of Social and Clinical Pharmacy Background and aim: Anticoagulants are widely used drugs especially indicated for the venous thromboembolism and atrial fibrillation. Increasing incidence of these diseases can be associated with an increasing trend in the utilization of anticoagulants. So far, there have been published studies focused mainly on the situation in the Western world, however data on the utilization of anticoagulants in Central and Eastern Europe has been rather lacking. The aim of this study was to analyze the utilization of anticoagulants in the Czech Republic (CR), Croatia, Hungary, Romania and Slovakia during 2007−2019. Methods: A retrospective utilization analysis was performed using the ATC/DDD methodology according to the WHO Collaborating Center for Drug Statistics Methodology. Drugs from the group B01AA (vitamin K antagonists), B01AB (heparins), B01AE (direct thrombin inhibitors), B01AF (direct factor Xa inhibitors) and B01AX (other anticoagulants, antithrombotics) were included in the analysis. The first...
|
guest ::
